• Je něco špatně v tomto záznamu ?

Mass Spectrometric Analysis of Exhaled Breath for the Identification of Volatile Organic Compound Biomarkers in Esophageal and Gastric Adenocarcinoma

S. Kumar, J. Huang, N. Abbassi-Ghadi, HA. Mackenzie, KA. Veselkov, JM. Hoare, LB. Lovat, P. Španěl, D. Smith, GB. Hanna,

. 2015 ; 262 (6) : 981-90.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu klinické zkoušky, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc16010634

OBJECTIVE: The present study assessed whether exhaled breath analysis using Selected Ion Flow Tube Mass Spectrometry could distinguish esophageal and gastric adenocarcinoma from noncancer controls. BACKGROUND: The majority of patients with upper gastrointestinal cancer present with advanced disease, resulting in poor long-term survival rates. Novel methods are needed to diagnose potentially curable upper gastrointestinal malignancies. METHODS: A Profile-3 Selected Ion Flow Tube Mass Spectrometry instrument was used for analysis of volatile organic compounds (VOCs) within exhaled breath samples. All study participants had undergone upper gastrointestinal endoscopy on the day of breath sampling. Receiver operating characteristic analysis and a diagnostic risk prediction model were used to assess the discriminatory accuracy of the identified VOCs. RESULTS: Exhaled breath samples were analyzed from 81 patients with esophageal (N = 48) or gastric adenocarcinoma (N = 33) and 129 controls including Barrett's metaplasia (N = 16), benign upper gastrointestinal diseases (N = 62), or a normal upper gastrointestinal tract (N = 51). Twelve VOCs-pentanoic acid, hexanoic acid, phenol, methyl phenol, ethyl phenol, butanal, pentanal, hexanal, heptanal, octanal, nonanal, and decanal-were present at significantly higher concentrations (P < 0.05) in the cancer groups than in the noncancer controls. The area under the ROC curve using these significant VOCs to discriminate esophageal and gastric adenocarcinoma from those with normal upper gastrointestinal tracts was 0.97 and 0.98, respectively. The area under the ROC curve for the model and validation subsets of the diagnostic prediction model was 0.92 ± 0.01 and 0.87 ± 0.03, respectively. CONCLUSIONS: Distinct exhaled breath VOC profiles can distinguish patients with esophageal and gastric adenocarcinoma from noncancer controls.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16010634
003      
CZ-PrNML
005      
20160412104525.0
007      
ta
008      
160408s2015 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1097/SLA.0000000000001101 $2 doi
024    7_
$a 10.1097/SLA.0000000000001101 $2 doi
035    __
$a (PubMed)25575255
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Kumar, Sacheen $u *Department of Surgery and Cancer, Imperial College London, St Mary's Hospital, London, UK †Department of Medicine, Imperial College London, St Mary's Hospital, London, UK ‡Department of Surgery and Interventional Science, National Medical Laser Centre, University College London, London, UK §J. Heyrovsky Institute of Physical Chemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic ¶Institute for Science and Technology in Medicine, Keele University, Guy Hilton Research Centre, Hartshill, UK.
245    10
$a Mass Spectrometric Analysis of Exhaled Breath for the Identification of Volatile Organic Compound Biomarkers in Esophageal and Gastric Adenocarcinoma / $c S. Kumar, J. Huang, N. Abbassi-Ghadi, HA. Mackenzie, KA. Veselkov, JM. Hoare, LB. Lovat, P. Španěl, D. Smith, GB. Hanna,
520    9_
$a OBJECTIVE: The present study assessed whether exhaled breath analysis using Selected Ion Flow Tube Mass Spectrometry could distinguish esophageal and gastric adenocarcinoma from noncancer controls. BACKGROUND: The majority of patients with upper gastrointestinal cancer present with advanced disease, resulting in poor long-term survival rates. Novel methods are needed to diagnose potentially curable upper gastrointestinal malignancies. METHODS: A Profile-3 Selected Ion Flow Tube Mass Spectrometry instrument was used for analysis of volatile organic compounds (VOCs) within exhaled breath samples. All study participants had undergone upper gastrointestinal endoscopy on the day of breath sampling. Receiver operating characteristic analysis and a diagnostic risk prediction model were used to assess the discriminatory accuracy of the identified VOCs. RESULTS: Exhaled breath samples were analyzed from 81 patients with esophageal (N = 48) or gastric adenocarcinoma (N = 33) and 129 controls including Barrett's metaplasia (N = 16), benign upper gastrointestinal diseases (N = 62), or a normal upper gastrointestinal tract (N = 51). Twelve VOCs-pentanoic acid, hexanoic acid, phenol, methyl phenol, ethyl phenol, butanal, pentanal, hexanal, heptanal, octanal, nonanal, and decanal-were present at significantly higher concentrations (P < 0.05) in the cancer groups than in the noncancer controls. The area under the ROC curve using these significant VOCs to discriminate esophageal and gastric adenocarcinoma from those with normal upper gastrointestinal tracts was 0.97 and 0.98, respectively. The area under the ROC curve for the model and validation subsets of the diagnostic prediction model was 0.92 ± 0.01 and 0.87 ± 0.03, respectively. CONCLUSIONS: Distinct exhaled breath VOC profiles can distinguish patients with esophageal and gastric adenocarcinoma from noncancer controls.
650    _2
$a adenokarcinom $x diagnóza $x metabolismus $7 D000230
650    _2
$a senioři $7 D000368
650    _2
$a nádorové biomarkery $x metabolismus $7 D014408
650    _2
$a dechové testy $7 D001944
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a metody pro podporu rozhodování $7 D003661
650    _2
$a nádory jícnu $x diagnóza $x metabolismus $7 D004938
650    _2
$a vydechnutí $7 D045853
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    12
$a hmotnostní spektrometrie $7 D013058
650    _2
$a lidé středního věku $7 D008875
650    _2
$a ROC křivka $7 D012372
650    _2
$a hodnocení rizik $7 D018570
650    _2
$a nádory žaludku $x diagnóza $x metabolismus $7 D013274
650    _2
$a těkavé organické sloučeniny $x metabolismus $7 D055549
655    _2
$a klinické zkoušky $7 D016430
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Huang, Juzheng
700    1_
$a Abbassi-Ghadi, Nima $7 gn_A_00000226
700    1_
$a Mackenzie, Hugh A
700    1_
$a Veselkov, Kirill A
700    1_
$a Hoare, Jonathan M
700    1_
$a Lovat, Laurence B
700    1_
$a Španěl, Patrik
700    1_
$a Smith, David
700    1_
$a Hanna, George B
773    0_
$w MED00009202 $t Annals of surgery $x 1528-1140 $g Roč. 262, č. 6 (2015), s. 981-90
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25575255 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160408 $b ABA008
991    __
$a 20160412104609 $b ABA008
999    __
$a ok $b bmc $g 1114063 $s 935002
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 262 $c 6 $d 981-90 $i 1528-1140 $m Annals of surgery $n Ann Surg $x MED00009202
LZP    __
$a Pubmed-20160408

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...